期刊
TRANSPLANT INFECTIOUS DISEASE
卷 23, 期 3, 页码 -出版社
WILEY
DOI: 10.1111/tid.13542
关键词
CAR‐ T cell therapy; H275Y; lung transplant; lymphoma; neuraminidase inhibitor
资金
- National Health and Medical Research Council [APP1176324, APP1169514]
Limited treatment options are available for oseltamivir-resistant influenza, with baloxavir being proposed as a potentially effective alternative. Clinical experience with baloxavir in immunocompromised patients is still lacking, and further research is needed in this area.
Few treatment options are available for oseltamivir-resistant influenza. It has been proposed that baloxavir can be effective in this setting due to its distinct mechanism of action but clinical experience is lacking for immunocompromised patients. We report two such cases treated with baloxavir after failure of oseltamivir and detection of oseltamivir resistance mutations. Baloxavir/zanamivir combination therapy was effective in one patient, but persistent viral shedding was noted with baloxavir monotherapy in the other patient.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据